Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Kissei Pharmaceutical Co ( (JP:4547) ) has provided an announcement.
Kissei Pharmaceutical Co., Ltd. reported a 13.5% increase in net sales for the nine months ending December 31, 2024, compared to the previous year. Despite this growth, the company experienced a decline in ordinary profit by 13.1%, though profit attributable to owners rose by 6.0%. The company’s financial position remained strong with a high equity ratio of 84.4%. No revisions were made to the previously announced forecast for the fiscal year ending March 31, 2025, indicating stable expectations despite the challenges reflected in ordinary profit.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. It specializes in the development and distribution of pharmaceutical products, focusing on innovation and addressing unmet medical needs.
YTD Price Performance: -2.56%
Average Trading Volume: 750
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $1.07B
Find detailed analytics on 4547 stock on TipRanks’ Stock Analysis page.
